In an AD mouse model (APP/PS1), the depletion of Tregs exacerbated cognitive dysfunction, accompanied by reducing the recruitment of microglia toward the amyloid beta plaques and lingered disease-related gene expression profile, and behavioral impairments, which were rescued by enhancing Tregs with low-dose IL-2 treatment (127). The gene discussed is APP; the disease is Alzheimer disease.